SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in LH — Labcorp Holdings Inc.

CIK 1232395 NEW YORK, NY

Position in LH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,076,680

-$349,701 QoQ

Shares Held

18,131

-10.9% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#241

of 1,047 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $153,900,221 across 13 Diagnostics & Research names. LH ranks #8 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	104,046	$52,164,502
2	DGX	Quest Diagnostics Inc	126,888	$26,893,911
3	RDNT	RadNet, Inc.	351,756	$21,692,792
4	DHR	Danaher Corp /De/	98,198	$18,704,755
5	A	Agilent Technologies, Inc.	79,608	$10,574,330
6	CDNA	CareDx, Inc.	296,200	$8,441,700
7	CSTL	Castle Biosciences Inc	256,095	$6,107,865
8	LH	Labcorp Holdings Inc. This page	18,131	$5,076,680

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,076,680	18,131	-10.9%	Shares	Sole	2026-08-14
2026-03-31	$5,426,381	20,338	-0.5%	Shares	Sole	2026-05-15
2025-12-31	$5,127,485	20,438	0.0%	Shares	Sole	2026-02-17
2025-09-30	$5,866,932	20,438	-0.2%	Shares	Sole	2025-11-14
2025-06-30	$5,373,842	20,471	+0.3%	Shares	Sole	2025-08-14
2025-03-31	$4,752,318	20,419	-12.3%	Shares	Sole	2025-05-15
2024-12-31	$5,338,798	23,281	-0.9%	Shares	Sole	2025-02-14
2024-09-30	$5,250,886	23,496	-0.1%	Shares	Sole	2024-11-14
2024-06-30	$4,788,793	23,531	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.